Gainplan’s Bio-Path Holdings Inc BPTH Stock Holding History

Gainplan’s Portfolio BPTH Stock Details BPTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-500	Closed	-$204K	–	46
2019 Q1	$204K	Buy	+500	New	+$91.9K	0.23%	21

Other funds holding BPTH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Gainplan's BPTH Position: Q2 2019 in Review

Gainplan sold out of Bio-Path Holdings Inc (BPTH) in Q2 2019, closing a stake of 500 shares — an estimated $204K sold.

Gainplan first reported a position in BPTH in Q1 2019 and held it in 1 quarter. The position peaked at $204K in Q1 2019. 17 funds tracked by Wall St. Rank hold BPTH as of Q2 2019.

Gainplan reported no remaining Bio-Path Holdings Inc position as of Q2 2019 after selling out during the quarter.
Gainplan sold 500 Bio-Path Holdings Inc shares in Q2 2019, an estimated $204K.
Gainplan first reported a position in Bio-Path Holdings Inc in Q1 2019 and held it in 1 quarter.
Gainplan's Bio-Path Holdings Inc position peaked at $204K in Q1 2019.
17 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2019.

Based on Gainplan's 13F filing for Q2 2019, filed 7 Aug 2019.